FDA & COVID: US Clinical Studies & Market Access Discussion - McDermott Skip to main content

FDA & COVID-19: Discussion on Clinical Studies and Market Access in the United States

FDA & COVID-19: Discussion on Clinical Studies and Market Access in the United States

Overview


Anisa Mohanty will be joining France Biotech to discuss legal and regulatory considerations when running clinical trials, managing supply chain risk, the FDA’s engagement strategies and more.

For additional information and to register, click here.

Dig Deeper

Boston, MA / In-person / November 13, 2025

Life Sciences Investment Forum 2025

Chicago, IL & Virtual / In-person / October 28, 2025

Healthcare Litigation, Compliance, and Investigations Forum 2025

New York, NY / In-person / October 16, 2025

HPE NYC 2025

Atlanta, Georgia / Speaking Engagements / October 8, 2025

Advanced Health Law

Paris, France / Speaking Engagements / October 7-8, 2025

HTID | Healthtech Innovation Days 2025

Verona, WI / Speaking Engagements / September 24-25, 2025

Open@Epic Conference 2025